Changes in metabolic profile among antiretroviral-naive patients initiating protease inhibitor versus non-protease inhibitor containing HAART regimens.
Visnegarwala
Fehmida
F
Darcourt
Jorge
J
Sajja
Prasuna
P
Menon
Vandana
V
Ong
Oliver
O
Maldonado
Mario
M
White
A Clinton
AC
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D001786:Blood Glucose / Q000032:analysis; D015992:Body Mass Index; D015331:Cohort Studies; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D013997:Time Factors
D001786:Blood Glucose; D017320:HIV Protease Inhibitors; D007328:Insulin; D008055:Lipids; D018894:Reverse Transcriptase Inhibitors